AccessPak for HIV PEP Expanded with Kaletra Interactions
There are 915 drugs known to interact with AccessPak for HIV PEP Expanded with Kaletra (emtricitabine/lopinavir/ritonavir/tenofovir disoproxil), along with 12 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 401 are major, 484 are moderate, and 30 are minor.
- View all 915 medications that may interact with AccessPak for HIV PEP Expanded with Kaletra
- View AccessPak for HIV PEP Expanded with Kaletra alcohol/food interactions (5)
- View AccessPak for HIV PEP Expanded with Kaletra disease interactions (12)
Most frequently checked interactions
View interaction reports for AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil) and the medicines listed below.
- alendronate
- amlodipine
- armodafinil
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Basaglar (insulin glargine)
- BeneFix (coagulation factor ix)
- betamethasone topical
- Bexxar (iodine i 131 tositumomab)
- celecoxib
- CellCept (mycophenolate mofetil)
- ciprofloxacin
- clindamycin topical
- clobetasol topical
- Coreg (carvedilol)
- cranberry
- dicyclomine
- Dificid (fidaxomicin)
- Doans Pills Extra Strength (magnesium salicylate)
- Dulcolax (bisacodyl)
- Easprin (aspirin)
- Eldepryl (selegiline)
- Enbrel (etanercept)
- EpiPen (epinephrine)
- ezetimibe
- famotidine
- Fast Sleep (doxylamine)
- fidaxomicin
- Klonopin (clonazepam)
AccessPak for HIV PEP Expanded with Kaletra alcohol/food interactions
There are 5 alcohol/food interactions with AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil).
AccessPak for HIV PEP Expanded with Kaletra disease interactions
There are 12 disease interactions with AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil) which include:
- hepatitis B
- hepatotoxicity
- hemodialysis
- renal dysfunction
- hemophilia
- hyperglycemia
- hyperlipidemia
- heart block
- hepatotoxicity
- bone toxicity
- liver disease
- renal dysfunction
Report options
More about AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil)
- AccessPak for HIV PEP Expanded with Kaletra consumer information
- Compare alternatives
- Side effects
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Lamivudine
Lamivudine is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational exposure
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.